Currently, Qiagen NV [QGEN] is trading at $41.43, up 6.75%. An important factor to consider is whether the stock is rising or falling in short-term value. The QGEN shares have gain 3.52% over the last week, with a monthly amount glided 5.55%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Qiagen NV [NYSE: QGEN] stock has seen the most recent analyst activity on April 04, 2025, when Redburn Atlantic downgraded its rating to a Neutral. Previously, Robert W. Baird downgraded its rating to Neutral on February 19, 2025, and dropped its price target to $42. On January 06, 2025, downgrade downgraded it’s rating to Equal-Weight but maintained its price target of $48 on the stock. Jefferies upgraded its rating to a Buy and increased its price target to $54 on December 10, 2024. HSBC Securities downgraded its rating to a Hold but $49 remained the price target by the analyst firm on October 17, 2024. Wolfe Research upgraded its rating to Outperform for this stock on June 27, 2024, but kept the price target unchanged to $50. In a note dated December 19, 2023, Wells Fargo initiated an Equal Weight rating and provided a target price of $44 on this stock.
This stock has fluctuated between a low of $37.63 and a high of $47.92 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $49 within the next 12 months. Qiagen NV [NYSE: QGEN] shares were valued at $41.43 at the most recent close of the market. An investor can expect a potential return of 18.27% based on the average QGEN price forecast.
Analyzing the QGEN fundamentals
Trailing Twelve Months sales for Qiagen NV [NYSE:QGEN] were 1.98B which represents 2.36% growth. Gross Profit Margin for this corporation currently stands at 0.5% with Operating Profit Margin at 0.05%, Pretax Profit Margin comes in at 0.06%, and Net Profit Margin reading is 0.04%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.02 and Total Capital is 0.02. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.39.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 39.80 points at the first support level, and at 38.16 for the second support level. However, for the 1st resistance point, the stock is sitting at 42.36, and for the 2nd resistance point, it is at 43.28.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Qiagen NV [NYSE:QGEN] is 3.61. On the other hand, the Quick Ratio is 3.09, and the Cash Ratio is 1.22. Considering the valuation of this stock, the price to sales ratio is 4.53, the price to book ratio is 2.51 and price to earnings (TTM) ratio is 111.52.
Transactions by insiders
Recent insider trading involved Sackers Roland, Officer, that happened on Sep 11 ’24 when 25000.0 shares were purchased.
